SNHG15

ncRNA information

ncRNA name

SNHG15

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-381-3p/GFRA1

Cancer information

Cancer name

Osteosarcoma

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p/GFRA1 axis

Tissue resource

doxorubicin-sensitive and doxorubicin-resistant osteosarcoma samples

osteoblast cell line hFOB

osteosarcoma cell lines SaOS-2

osteosarcoma cell lines U2OS

osteosarcoma cell lines HOS

osteosarcoma cell lines MG63

Experiment

None


Institute

Jingzhou Central Hospital, Second Clinical College of Yangtze University

BeNa Culture Collection

Country

China

China

Continent

Asia

Asia